Literature DB >> 814849

Radiation therapy of midline granuloma.

A S Fauci, R E Johnson, S M Wolff.   

Abstract

During a 15-year period, 10 patients with well-documented midline granuloma were treated with high-dose, deep local irradiation and followed for extended periods of time. Long-term remissions were achieved in 7 patients, with a mean (+/- SEM) survival postirradiation of 7.4 (+/- 1.4) years in the 6 patients still alive. True midline granuloma, which is a localized, destructive, inflammatory process of the upper airways, can be distinguished from Wegener's granulomatosis and neoplasms of the upper respiratory tract by several clinicopathologic criteria. The cause of midline granuloma is unknown, but it most likely represents an abnormal accelerated hypersensitivity reaction to an unknown antigen(s). Although serious complications of high-dose local irradiation to the upper airways can occur, the risk is warranted because of the high, long-term remission rate in this previously uniformly fatal disease.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 814849     DOI: 10.7326/0003-4819-84-2-140

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  5 in total

1.  Wegener's granulomatosis presenting as rheumatoid arthritis.

Authors:  I Friedmann
Journal:  Proc R Soc Med       Date:  1976-10

2.  Idiopathic midline destructive disease--case report and review of the literature.

Authors:  A C Robinson; I Fraser; D Bailey; M J O'Halloran
Journal:  Postgrad Med J       Date:  1984-07       Impact factor: 2.401

3.  Mutilating Lesions of Face.

Authors:  Kavita Sachdeva; Aparaajita Upadhyay
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2017-09-09

4.  A case of NK/T-cell lymphoma complicated by a squamous cell carcinoma of hard palate during combination chemotherapy and radiation therapy.

Authors:  Hang Lak Lee; Myung Ju Ahn; Jung Hye Choi; Woon Hyun Jun; Young Yuel Lee; In Soon Kim; Il Young Choi; Se Jin Jang; Yong Wook Park
Journal:  Korean J Intern Med       Date:  2002-03       Impact factor: 2.884

5.  L-asparaginase-based regimen in the treatment of refractory midline nasal/nasal-type T/NK-cell lymphoma.

Authors:  Weiben Yong; Wen Zheng; Yuntao Zhang; Jun Zhu; Yan Wei; Deliang Zhu; Jiyou Li
Journal:  Int J Hematol       Date:  2003-08       Impact factor: 2.319

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.